Studies related to Cognitive Decline and Yamabushitake

Improving Effects Of The Mushroom Yamabushitake (Hericium Erinaceus) On Mild Cognitive Impairment: A Double-blind Placebo-controlled Clinical Trial

Effect Decrease
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 30
Sex Both Genders
Age Range 45-64, 65+
Body Types Average
Notes for this study:
Subjects between 50 and 80 that suffered from non-clinical cognitive impairment has improvement as measured by the 'Revised Hasegawa Dementia Scale' with 3g of 96% Yamabushitake daily for 16 weeks.

Full details on all 1 studies are available to Examine Plus members.

Already a member? Login now to access.